These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31778275)

  • 1. Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells.
    Choi KA; Park HK; Hwang I; Jeong H; Park HS; Jang AY; Namkung Y; Hyun D; Lee S; Yoo BM; Kwon HJ; Seol KC; Kim JO; Hong S
    Stem Cells; 2020 Apr; 38(4):516-529. PubMed ID: 31778275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
    Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
    BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.
    Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS
    Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.
    Cho SJ; Kim SY; Jeong HC; Cheong H; Kim D; Park SJ; Choi JJ; Kim H; Chung HM; Moon SH; Cha HJ
    Stem Cell Reports; 2015 Dec; 5(6):1067-1080. PubMed ID: 26584542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Producing Engraftable Skeletal Myogenic Progenitors from Pluripotent Stem Cells via Teratoma Formation.
    Xie N; Chan SSK
    Methods Mol Biol; 2023; 2640():175-189. PubMed ID: 36995595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy.
    Liu Y; Yang Y; Suo Y; Li C; Chen M; Zheng S; Li H; Tang C; Fan N; Lan T; Zhou J; Li Y; Wang J; Chen H; Zou Q; Lai L
    Mol Ther Methods Clin Dev; 2022 Mar; 24():332-341. PubMed ID: 35229007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.
    Neyrinck K; Breuls N; Holvoet B; Oosterlinck W; Wolfs E; Vanbilloen H; Gheysens O; Duelen R; Gsell W; Lambrichts I; Himmelreich U; Verfaillie CM; Sampaolesi M; Deroose CM
    Theranostics; 2018; 8(10):2799-2813. PubMed ID: 29774076
    [No Abstract]   [Full Text] [Related]  

  • 8. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pancreatic stellate cell activity by adipose-derived stem cells.
    Yu FX; Su LF; Dai CL; Wang Y; Teng YY; Fu JH; Zhang QY; Tang YH
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):215-21. PubMed ID: 25865696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
    Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
    Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The teratoma assay: an in vivo assessment of pluripotency.
    Wesselschmidt RL
    Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded potential stem cell media as a tool to study human developmental hematopoiesis in vitro.
    Wilkinson AC; Ryan DJ; Kucinski I; Wang W; Yang J; Nestorowa S; Diamanti E; Tsang JC; Wang J; Campos LS; Yang F; Fu B; Wilson N; Liu P; Gottgens B
    Exp Hematol; 2019 Aug; 76():1-12.e5. PubMed ID: 31326613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas.
    Pappas MP; Xie N; Penaloza JS; Chan SSK
    Cells; 2022 May; 11(9):. PubMed ID: 35563894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells: Basic biology or else differentiations aimed at translational research and the role of flow cytometry.
    Bose B; Nihad M; P SS
    Cytometry A; 2023 May; 103(5):368-377. PubMed ID: 36918734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts.
    Choi HW; Kim JS; Hong YJ; Song H; Seo HG; Do JT
    Sci Rep; 2015 Aug; 5():13559. PubMed ID: 26315499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential.
    Kim JS; Hong YJ; Choi HW; Song H; Byun SJ; Do JT
    Oncotarget; 2017 Mar; 8(10):16456-16462. PubMed ID: 28147316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Generation of Neural Stem Cells Through Teratoma Formation.
    Hong YJ; Kim JS; Choi HW; Song H; Park C; Do JT
    Stem Cells Dev; 2016 Sep; 25(17):1311-7. PubMed ID: 27439546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective eradication of pluripotent stem cells by inhibiting DHODH activity.
    Kondo T
    Stem Cells; 2021 Jan; 39(1):33-42. PubMed ID: 33038285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.
    Lehner S; Lang C; Kaissis G; Todica A; Zacherl MJ; Boening G; Spitzweg C; Herbach N; Franz WM; Krause BJ; Steinhoff G; Bartenstein P; Hacker M; David R
    Mol Imaging Biol; 2015 Dec; 17(6):874-83. PubMed ID: 25896817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.